Inclusion of molecular monitoring (BCR-ABL1) in the treatment of chronic myeloid leukemia in the Brazilian Public Health System (SUS): an urgent need for treatment management Carla Maria Boquimpani; André Neder Ramires Abdo; Denise Pires Martins; Luciana Britto de Abreu Lima; Mayde Seadi Torriani; Israel Bendit;

Ponatinib in the treatment of patients with chronic myeloid leukemia and increased cardiovascular risk: A review of management strategies Tomasz Sacha; Katarzyna Krawczyk;

Epidemiologic profile of hemoglobinopathies in Benin Selma Gomez; Adjile Edjide Roukiyath Amoussa; Edwige Dedjinou; Manasse Kakpo; Pélagie Gbédji; Nouhoum Amossou Soulé; Bernice Quenum;